Reduced serum albumin as a risk factor for poor prognosis in critically ill patients receiving renal replacement therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Reduced serum albumin as a risk factor for poor prognosis in critically ill patients receiving renal replacement therapy ; volume:22 ; number:1 ; day:8 ; month:9 ; year:2021 ; pages:1-11 ; date:12.2021
BMC nephrology ; 22, Heft 1 (8.9.2021), 1-11, 12.2021
- Urheber
-
Zheng, Lang Jing
Jiang, Weiming
Pan, Lingling
Pan, Jingye
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12882-021-02512-w
- URN
-
urn:nbn:de:101:1-2021112220310457772869
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zheng, Lang Jing
- Jiang, Weiming
- Pan, Lingling
- Pan, Jingye
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antibiotic dosing recommendations in critically ill patients receiving new innovative kidney replacement therapy
High-dose colistin pharmacokinetics in critically ill patients receiving continuous renal replacement therapy
Associations of continuous anionic gap detection with the mortality in critically ill patients receiving renal replacement therapy
Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study
Fluid removal associates with better outcomes in critically ill patients receiving continuous renal replacement therapy: a cohort study
Hyperoncotic Albumin Solution in Continuous Renal Replacement Therapy Patients
Relationship between reduced albumin and inflammation in the critically ill
Lacosamide dosing in patients receiving continuous renal replacement therapy
Blood volume and albumin transudation in critically ill COVID-19 patients
Renal replacement therapy for critically ill patients: an intermittent continuity
Mobilisation of critically ill patients receiving norepinephrine: a retrospective cohort study
Continuous kidney replacement therapy in critically ill children: heparin vs citrate
Antibiotic dosing recommendations in critically ill patients receiving new innovative kidney replacement therapy
High-dose colistin pharmacokinetics in critically ill patients receiving continuous renal replacement therapy
Associations of continuous anionic gap detection with the mortality in critically ill patients receiving renal replacement therapy
Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study
Fluid removal associates with better outcomes in critically ill patients receiving continuous renal replacement therapy: a cohort study
Hyperoncotic Albumin Solution in Continuous Renal Replacement Therapy Patients
Relationship between reduced albumin and inflammation in the critically ill
Lacosamide dosing in patients receiving continuous renal replacement therapy
Blood volume and albumin transudation in critically ill COVID-19 patients
Renal replacement therapy for critically ill patients: an intermittent continuity
Mobilisation of critically ill patients receiving norepinephrine: a retrospective cohort study
Continuous kidney replacement therapy in critically ill children: heparin vs citrate
Antibiotic dosing recommendations in critically ill patients receiving new innovative kidney replacement therapy
High-dose colistin pharmacokinetics in critically ill patients receiving continuous renal replacement therapy
Associations of continuous anionic gap detection with the mortality in critically ill patients receiving renal replacement therapy
Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study
Fluid removal associates with better outcomes in critically ill patients receiving continuous renal replacement therapy: a cohort study
Hyperoncotic Albumin Solution in Continuous Renal Replacement Therapy Patients
Relationship between reduced albumin and inflammation in the critically ill
Lacosamide dosing in patients receiving continuous renal replacement therapy
Blood volume and albumin transudation in critically ill COVID-19 patients
Renal replacement therapy for critically ill patients: an intermittent continuity
Mobilisation of critically ill patients receiving norepinephrine: a retrospective cohort study